Lantern Pharma (LTRN) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.54
-0.49
-0.44
-0.39

Details

Expected EPS
-0.47
Actual EPS
-0.39
Surprise EPS
0.08
Surprise Percent
+17.02%

Description

Lantern Pharma (LTRN) has reported earnings of -0.39 per share for Q4 2025.

0 Comments

Share your thoughts